# Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)

> **NCT03088839** · — · UNKNOWN · sponsor: **Neuromed IRCCS** · enrollment: 60 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03088839
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088839, "Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03088839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*